title: Pharmaceutical patent law: the Canadian perspective.
abstract: This article provides an overview of the patent regime in Canada, with a focus on issues most relevant to the pharmaceutical industry. The process of applying for a patent is discussed, as well as enforcement and litigation. Recent developments in the case law dealing with patentability requirements - novelty, obviousness, utility and sufficiency - are reviewed. Finally, the impact of recently negotiated trade agreements on Canadian patent law is addressed. In this article, we aim to provide an overview of the patent regime in Canada, with a focus on issues that are particularly relevant to the pharmaceutical industry.
authors.affiliation: Gowling WLG (Canada) LLP, 160 Elgin Street Suite 2600, Ottawa, Ontario K2P 1C3, Canada.
authors.forename: Livia
authors.initials: L
authors.lastname: Aumand
authors.affiliation: Gowling WLG (Canada) LLP, 160 Elgin Street Suite 2600, Ottawa, Ontario K2P 1C3, Canada.
authors.forename: John
authors.initials: J
authors.lastname: Norman
mesh_terms: D002170:Canada; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*
keywords: Canada; biologics; drugs; generic; infringement; innovators; pharmaceuticals; validity